Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Advances in Therapy|May 28, 2023
Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based ChemotherapyRudolph M Navari, Winnie W Nelson, Sofia Shoaib, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2023
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomitingBernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, et al.
Drug Design, Development and Therapy|September 19, 2017
Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populationsBernardo Leon Rapoport, Matti Aapro, Martin R Chasen, et al.
Cancer Investigation|October 21, 2004
A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group studySteven D Passik, Rudolph M Navari, Sin-Ho Jung, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 13, 2005
Cathepsin E is a specific marker of dysplasia in APC mouse intestineLizette Busquets, Hector Guillen, Melanie E DeFord, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 23, 2016
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk ChemotherapyJørn Herrstedt, Fausto Roila, David Warr, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 14, 2021
Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literatureRonald Chow, Jørn Herrstedt, Matti Aapro, et al.
Investigative Radiology|August 24, 2018
Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Point-of-Care Perfusion Phantom: A Pilot StudyHarrison Kim, Desiree E Morgan, Patrick Schexnailder, et al.
JAMA Oncology|May 8, 2020
Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and/or Vomiting: A Randomized Pilot TrialRudolph M Navari, Cameron M Pywell, Jennifer G Le-Rademacher, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 26, 2018
Should palonosetron be a preferred 5-HT<sub>3</sub> receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysisRonald Chow, David G Warr, Rudolph M Navari, et al.
Pageof 8